A Walewska, A Janucik, M Tynecka, M Moniuszko… - Cell Death & …, 2023 - nature.com
Mesenchymal stem cells (mesenchymal stromal cells, MSC) are multipotent stem cells that can differentiate into cells of at least three mesodermal lineages, namely adipocytes …
H Ai, GC Chu, Q Gong, ZB Tong, Z Deng… - Journal of the …, 2022 - ACS Publications
The chemical synthesis of homogeneously modified histones is a powerful approach to quantitatively decipher how post-translational modifications (PTMs) modulate epigenetic …
Shelterin and nucleosomes are the key players that organize mammalian chromosome ends into the protective telomere caps. However, how they interact with each other at telomeres …
Z Tong, H Ai, Z Xu, K He, GC Chu, Q Shi… - Nature Structural & …, 2024 - nature.com
The cancer-specific fusion oncoprotein SS18–SSX1 disturbs chromatin accessibility by hijacking the BAF complex from the promoters and enhancers to the Polycomb-repressed …
W Shi, T Wang, Z Yang, Y Ren, D Han… - Angewandte …, 2024 - Wiley Online Library
D‐peptide ligands can be screened for therapeutic potency and enzymatic stability using synthetic mirror‐image proteins (D‐proteins), but efficient acquisition of these D‐proteins …
Genetic and genomic techniques have proven incredibly powerful for identifying and studying molecular players implicated in the epigenetic regulation of DNA-templated …
S Dong, JS Zheng, Y Li, H Wang, G Chen… - Science China …, 2024 - Springer
The central dogma of modern biology underscores the pivotal roles proteins play in diverse biological processes, the study of which necessitates advanced methods to produce …
X Sheng, Z Xia, H Yang, R Hu - Protein & cell, 2024 - academic.oup.com
Ubiquitination/ubiquitylation, one of the most fundamental post-translational modifications, regulates almost every critical cellular process in eukaryotes. Emerging evidence has shown …
XY Fu, H Yin, XT Chen, JF Yao, YN Ma… - Journal of Medicinal …, 2024 - ACS Publications
Oncolytic peptides represent promising novel candidates for anticancer treatments. In our efforts to develop oncolytic peptides possessing both high protease stability and durable …